{
    "clinical_study": {
        "@rank": "122559", 
        "arm_group": [
            {
                "arm_group_label": "Experimental:   Tele-medicine monitoring", 
                "arm_group_type": "Experimental", 
                "description": "Tele-medicine monitoring of medication adherence will be given to the study group as an add-on to routine out-patient treatment"
            }, 
            {
                "arm_group_label": "No Intervention:   Control Rutine out-patient treatment", 
                "arm_group_type": "No Intervention", 
                "description": "routine out-patient treatment will be given to the control group"
            }
        ], 
        "brief_summary": {
            "textblock": "Schizophrenia is a chronic debilitating mental disorder, characterised by a relapsing\n      remitting course. Although anti-psychotics can prevent relapse, its effect on schizophrenia\n      outcome remains very limited, mainly due to very poor adherence to medications by the\n      patients. This study aims to find, whether the add-on of remote monitoring of medication\n      compliance via tele-medicine, to routine out-patient clinic care, can improve patients\n      adherence and reduce the risk of relapse."
        }, 
        "brief_title": "Measuring the Effect of Remote Monitoring of Treatment Adherence on the Risk of Re-admission of Ambulatory Schizophrenic Patients", 
        "completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Schizophrenia", 
            "Schizoaffective Disorder"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Psychotic Disorders", 
                "Schizophrenia"
            ]
        }, 
        "detailed_description": {
            "textblock": "Schizophrenia is a chronic debilitating mental disorder, characterised by a relapsing\n      remitting course. Although anti-psychotics can prevent relapse, its effect on schizophrenia\n      outcome remains very limited, mainly due to very poor adherence to medications by the\n      patients. This study aims to find, whether the add-on of remote monitoring of medication\n      compliance via tele-medicine, to routine out-patient clinic care, can improve patients\n      adherence and reduce the risk of relapse. The study is an uni center, open, prospective,\n      randomised and controlled."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  DSM 4 diagnosis of schizophrenia or schizoaffective\n\n          -  able to give written informed consent\n\n          -  Have a telephone line\n\n        Exclusion Criteria:\n\n          -  Are not discharged to a place with routine medication monitoring\n\n          -  Are not discharged under forced ambulatory treatment order\n\n          -  Are not homeless\n\n          -  Are not admitted due to drug intoxication or withdrawal.\n\n          -  Are not admitted due to severe self harm."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 14, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01729572", 
            "org_study_id": "0004-12-SHA"
        }, 
        "intervention": {
            "arm_group_label": "Experimental:   Tele-medicine monitoring", 
            "intervention_name": "Tele-medicine monitoring of medication adherence", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "schizophrenia", 
            "Schizoaffective Disorder", 
            "disease management", 
            "treatment", 
            "rehabilitation", 
            "pharmacotherapy"
        ], 
        "lastchanged_date": "April 24, 2014", 
        "location": {
            "contact": {
                "email": "israelkr@clalit.org.il", 
                "last_name": "Israel Krieger, Dr' Med", 
                "phone": "+97297478665"
            }, 
            "facility": {
                "address": {
                    "city": "Hod-Hasharon", 
                    "country": "Israel", 
                    "zip": "45100"
                }, 
                "name": "Shalvata MHC"
            }, 
            "investigator": {
                "last_name": "Israel Krieger, Dr' Med", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Effect of add-on Tele Medicine Monitoring of Medication Adherence, on the Risk of Re-hospitalisation of Ambulatory Schizophrenic Patients. an Open, Prospective, Randomised Controled Trial", 
        "other_outcome": {
            "description": "Total time in hospital during the 1 year follow-up period will be compared between the study and the control groups.", 
            "measure": "Total time in hospital", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "overall_contact": {
            "email": "israelkr@clalit.org.il", 
            "last_name": "Israel Krieger, Dr. Med", 
            "phone": "+97297478665"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Time to re-hospitalisation will be compared in the study group and in the control group during the follow-up period of up to one year", 
            "measure": "Time to re-hospitalisation", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01729572"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "number of re-hospitalisations will be compared among the study and the control groups during the 1 year follow-up.", 
            "measure": "number of re-hospitalisations", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "source": "Shalvata Mental Health Center", 
        "sponsors": {
            "collaborator": {
                "agency": "SHL Telemedicine Ltd.", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Shalvata Mental Health Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}